-
Glaucoma Drugs
- Decrease IOP but decreasing amount of aqueous humor
- -inhibit synthesis/secretion
- -increase drainage
- α-Agonists
- -epinephrine
- -Brimonidine
- β-Blockers
- -Timolol
- -Betaxolol
- -Carteolol
- Cholinomimetics
- -Pilocarpine
- -Carbachol
- -Physostigmine
- -Echothiophate
- Prostaglandin
- -Latanoprost
-
Epinephrine
- Mechanism:
- -α-agonist
- -decreased aqueous humor synthesis via vasoconstriction
- Adverse Effects:
- -mydriasis
- -do not use in closed-angle glaucoma
-
Brimonidine
- Mechanism:
- -α2 agonist
- -decrease aqueous humor synthesis
- Adverse Effects:
- -blurry vision
- -ocular hyperemia
- -foreign body sensation
- -ocular allergic reactions
- -ocular pruritus
-
β-Blockers
- Timolol
- Betaxolol
- Carteolol
- Mechanism:
- -β antagonist
- -decrease aqueous humor synthesis
- Adverse Effects:
- -no pupillary or vision changes
-
Acetazolamide
- Mechanism:
- -diuretic
- -decrease aqueous humor synthesis via inhibition of carbonic anhydrase
- Adverse Effects:
- -no pupillary or vision changes
-
Cholinomimetics
- Direct:
- -Pilocarpine
- -Carbachol
- Indirect:
- -Physostigmine
- -Echothiophate
- Mechanism:
- - increase outflow of aqueous humor via contraction of ciliary muscle and opening of trabecular meshwork
- Clinical Uses:
- -glaucoma
- *use pilocarpine in emergencies: very effective at opening meshwork into canal of Schlemm
- Adverse Effects:
- -miosis
- -cyclospasm (contraction of ciliary muscle)
-
Latanoprost
- Mechanism:
- -prostaglandin analog (PGF2a)
- -increase outflow of aqueous humor
- Adverse Effects:
- -darkens color of iris (browning)
-
Opioid Analgesics
- Morphine
- Fentanyl
- Codeine
- Heroin
- Methadone
- Merperidine
- Dextromethorphan
- Diphenoxylate
- Mechanism:
- -agonists at opioid receptors
- -mu → morphine
- -delta → enkephalin
- -kappa → dynorphin
- -modulate synaptic transmission: opens K+ channels, closes Ca2+ channels
- -decreases synaptic transmission
- -inhibits release of ACh, NE, 5-HT, glutamate, substanceP
- Clinical Use:
- -pain
- -cough suppression (dextromethorphan)
- -diarrhea (loperamide and diphenoxylate)
- -acute pulmonary edema
- -maintenance programs for addicts (methadone)
- Toxicity:
- -addiction
- -respiratory depression
- -constipation
- -miosis (pinpoint pupils)
- -additive CNS depression with other drugs
- -tolerance does not develop to miosis and constipation
- -toxicity treated with naloxone or naltrexone (opioid receptor antagonist)
-
Butorphanol
- Mechanism:
- -mu opioid receptor partial agonist and kappa opioid receptor agonist
- -produces analgesia
- Clinical Use:
- -severe pain (migraine, labor etc)
- -causes less respiratory depression than full opioid agonist
- Toxicity:
- -can cause opioid withdrawal symptoms if patient is also taking full opioid agonist (competition for opioid receptors)
- -OD not easily reversed with naloxone
-
Tramadol
- Mechanism:
- -very weak opioid agonist
- -also inhibits serotonin and NE reuptake
- "Works with multiple NTs: "tram it all" in with tramadol"
- Clinical Use:
- -chronic pain
- Toxicity:
- -similar to opioids
- -decreases seizure threshold
-
Epilepsy
- Phenytoin
- Carbamazepine
- Lamotrigine
- Gabapentine
- Topiramate
- Phenobarbital
- Valproic Acid
- Ethosuximide
- Benzodiazepines
- Tiagabine
- Vigabatrin
- Levetiracetam
-
Phenytoin (Seizures)
- Mechanism:
- -increase Na+ channel inactivation
- Clinical Use:
- -simple partial seizures
- -complex partial seizures
- -First line for tonic-clonic seizures
- -First line for prophylaxis of status epilepticus
- Toxicity:
- -nystagmus
- -diplopia
- -ataxia
- -sedation
- -gingival hyperplasia
- -hirsutism
- -megaloblastic anemia
- -teratogenesis (fetal hydantoin syndrome)
- -SLE-like syndrome
- -induction of cytochrome P-450
- -lymphadenopathy
- -Stevens-Johnson Syndrome
- -osteopenia
- Notes:
- -Fosphenytoin for parenteral use
-
Carbamazepine
- Mechanism:
- -increase Na+ channel inactivation
- Clinical Use:
- -first line for simple partial seizures
- -first line for complex partial seizures
- -first line for tonic-clonic seizures
- -first line for Trigeminal Neuralgia
- Toxicity:
- -diplopia
- -ataxia
- -blood dyscrasias (agranulocytosis, aplastic anemia)
- -liver toxicity
- -teratogenesis
- -induction of cytochrome P-450
- -SIADH
- -Stevens-Johnson syndrome
-
Lamotrigine
- Mechanism:
- -blocks voltage gated Na+ channels
- Clinical Use:
- -simple partial seizures
- -simple complex seizures
- -tonic-clonic seizures
- Toxicity:
- -Stevens-Johnson Syndrome
-
Gabapentin
- Mechanism:
- -designed as a GABA analog
- -primarily inhibits high voltage activated Ca2+ channels
- Clinical Use:
- -simple partial seizures
- -simple complex seizures
- -tonic-clonic seizures
- -peripheral neuropathy
- -postherpetic neuralgia
- -migraine prophylaxis
- -bipolar disorder
- Toxicity:
- -sedation
- -ataxia
-
Topiramate
- Mechanism:
- -blocks Na+ channels
- -increases GABA action
- Clinical Use:
- -simple partial seizures
- -complex partial seizures
- -tonic-clonic seizures
- -migraine prevention
- Toxicity:
- -sedation
- -mental dulling
- -kidney stones
- -weight loss
-
Phenobarbital
- Mechanism:
- -increase GABAA action
- Clinical Use:
- -simple partial seizures
- -simple complex seizures
- -tonic-clonic seizures
- **first line in children
- Toxicity:
- -sedation
- -tolerance
- -dependence
- -induction of cytochrome P-450
-
Valproic Acid
- Mechanism:
- -increase Na+ channel inactivation
- -increase GABA concentration
- Clinical Use:
- -simple partial seizures
- -simple complex seizures
- -first line for tonic-clonic seizures
- -absence seizures
- -myoclonic seizures
- Toxicity:
- -GI distress
- -rare but fatal hepatotoxicity (measure LFTs)
- -neural tube defects in fetus (spina bifida)
- -tremor
- -weight gain
- -CI in pregnancy
-
Ethosuximide
- Mechanism:
- -blocks thalamic T-type Ca2+ channels
- Clinical Use:
- -first line for absence seizures
- Toxicity:
- -GI distress
- -fatigue
- -headache
- -urticaria
- -Stevens-Johnson syndrome
- EFGH
- -Ethosuximide
- -Fatigue
- -GI
- -Headache
-
Benzodiazepines
- Mechanism:
- -increase GABAA action
- Clinical Use:
- -first line for acute status epilepticus
- -seizures of eclampsia (first line is MgSO4)
- Toxicity:
- -sedation
- -tolerance
- -dependence
-
Tiagabine
- Mechanism:
- -inhibits GABA reuptake
- Clinical Use:
- -simple partial seizures
- -simple complex seizures
-
Vigabatrin
- Mechanism:
- -irreversibly binds GABA transaminase
- -increases GABA
- Clinical Use:
- -simple partial seizures
- -simple complex seizures
-
Levetiracetam
- Mechanism:
- -unknown
- -may modulate GABA and glutamate release
- Clinical Use:
- -simple partial seizures
- -simple complex seizures
- -tonic-clonic seizures
|
|